Innovation
3 patent families — focus: Chemistry & metallurgy; filing pace slowing. Cited 59 times.
| Year | Filings |
|---|---|
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 2 |
Investor mix
7 investors on record; lead investors include Massachusetts Life Sciences Center, Bristol-Myers Squibb, Charles River Laboratories, Asahi Kasei.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 29% |
| Accelerator & incubator | 1 | 14% |
| Other / undisclosed | 4 | 57% |